| Product No | EMEA/H/C/006019 |
|---|---|
| Brand Name | COVID-19 Vaccine (inactivated, adjuvanted) Valneva |
| Nonproprietary Name | COVID-19 vaccine (inactivated, adjuvanted, adsorbed) |
| API | SARS-CoV-2 virus (inactivated) Wuhan strain hCoV-19 / Italy / INMI1-isl / 2020 |
| ATC Code | J07BX03 |
| Indications | COVID-19 Vaccine (inactivated, adjuvanted) Valneva is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 18 to 50 years of age. The use of this vaccine should be in accordance with official recommendations. |
| Orphan Drug | no |
| Generics | no |
| Marketing Authorization Holder | Valneva Austria GmbH |
| Status | Authorised(授权) |
| Authorization Date | 2022-06-24 |
| Version | 6 |
| Condition Approval | no |
| Exceptions | no |
| Biosimilar | no |
| Details | 查看 (公众评估报告、授权细节、产品规格/剂型、标签、历史评估信息) |
Extended Information